A new heterotopic transplant animal model of intestinal fibrosis

Inflammatory Bowel Diseases

Volumn 19, Issue 11, 2013, Pages 2302-2314

  Hausmann, Martin ^a   Rechsteiner, Thomas ^a   Caj, Michaela ^a   Benden, Christian ^a   Fried, Michael ^a   Boehler, Annette ^a   Rogler, Gerhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Allogenic transplantation; Fibrosis; Lumen obliteration; Rats

Indexed keywords

ALPHA ACTIN; ALPHAVBETA6 INTEGRIN; COLLAGEN; CYTOKERATIN; INTERLEUKIN 13; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN NORWAY RAT; CONTROLLED STUDY; EXPLANT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINAL FIBROSIS; INTESTINE CRYPT; LEWIS RAT; LYMPHOCYTIC INFILTRATION; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SMALL INTESTINE RESECTION; XENOGRAFT;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; COLLAGEN; DISEASE MODELS, ANIMAL; FIBROSIS; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT SURVIVAL; IMMUNOENZYME TECHNIQUES; INTESTINE, SMALL; MALE; ORGAN TRANSPLANTATION; RATS; RATS, INBRED BN; RATS, INBRED LEW; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSPLANTATION, HETEROTOPIC;

EID: 84888264489     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e3182a6a0f3     Document Type: Article

References (46)

1. Jones MK, Tomikawa M, Mohajer B, et al. Gastrointestinal mucosal regeneration: role of growth factors. Front Biosci. 1999;4:D303-D309.
2. Rieder F, Brenmoehl J, Leeb S, et al. Wound healing and fibrosis in intestinal disease. Gut. 2007;56:130-139.
3. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohns disease. Gastroenterol Clin North Am. 1995;24:475-507.
4. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohns disease. Inflamm Bowel Dis. 2002;8:244-250.
5. Freeman HJ. Natural history and clinical behavior of Crohns disease extending beyond two decades. J Clin Gastroenterol. 2003;37:216-219.
6. Van Assche G, Geboes K, Rutgeerts P. Medical therapy for Crohns disease strictures. Inflamm Bowel Dis. 2004;10:55-60.
7. Sartor RB, Cromartie WJ, Powell DW, et al. Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology. 1985;89:587-595.
8. van Tol EA, Holt L, Li FL, et al. Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts. Am J Physiol. 1999;277:G245-G255.
9. Morris GP, Beck PL, Herridge MS, et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989;96:795-803.
10. Hele DJ, Yacoub MH, Belvisi MG. The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis. Respir Res. 2001;2:169-183.
11. Boehler A, Bai XH, Liu M, et al. Upregulation of T-helper 1 cytokines and chemokine expression in post-transplant airway obliteration. Am J Respir Crit Care Med. 1999;159:1910-1917.
12. Brazelton TR, Shorthouse R, Huang X, et al. Infiltrating recipient mesenchymal cells form the obliterative airway disease lesion and dramatically remodel graft tissue in a model of chronic lung rejection. Transplant Proc. 1997;29:2614.
13. Boehler A, Chamberlain D, Kesten S, et al. Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans. Transplantation. 1997;64:311-317.
14. Boehler A, Chamberlain D, Xing Z, et al. Adenovirus-mediated interleukin-10 gene transfer inhibits post-transplant fibrous airway obliteration in an animal model of bronchiolitis obliterans. Hum Gene Ther. 1998;9:541-551.
15. Hertz MI, Jessurun J, King MB, et al. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am J Pathol. 1993;142:1945-1951.
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-408.
17. Vick B, Weber A, Urbanik T, et al. Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes. Hepatology. 2009;49:627-636.
18. Haybaeck J, Zeller N, Wolf MJ, et al. A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell. 2009;16:295-308.
19. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182-205.
20. Pinzani M. Fibrosis in the GI tract: pathophysiology, diagnosis and treatment options. Front Gastrointest Res. 2010;26:15-31.
21. Brenmoehl J, Falk W, Goke M, et al. Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF). Int J Colorectal Dis. 2008;23:947-955.
22. Wells RG. Fibrogenesis. V. TGF-beta signaling pathways. Am J Physiol Gastrointest Liver Physiol. 2000;279:G845-G850.
23. Bates RC. Colorectal cancer progression: Integrin alphavbeta6 and the epithelial-mesenchymal transition (EMT). Cell Cycle. 2005;4: 1350-1352.
24. Bates RC, Bellovin DI, Brown C, et al. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest. 2005; 115:339-347.
25. Vaughan MB, Howard EW, Tomasek JJ. Transforming growth factorbeta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res. 2000;257:180-189.
26. Simmons JG, Pucilowska JB, Keku TO, et al. IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiol Gastrointest Liver Physiol. 2002;283:G809-G818.
27. Meier JK, Scharl M, Miller SN, et al. Specific differences in migratory function of myofibroblasts isolated from Crohns disease fistulae and strictures. Inflamm Bowel Dis. 2011;17:202-212.
28. Suganuma H, Sato A, Tamura R, et al. Enhanced migration of fibroblasts derived from lungs with fibrotic lesions. Thorax. 1995;50:984-989.
29. Leeb SN, Vogl D, Falk W, et al. Regulation of migration of human colonic myofibroblasts. Growth Factors. 2002;20:81-91.
30. Peters T, Sindrilaru A, Hinz B, et al. Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation. EMBO J. 2005;24:3400-3410.
31. Thampatty BP, Wang JH. A new approach to study fibroblast migration. Cell Motil Cytoskeleton. 2007;64:1-5.
32. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003;112:1776-1784.
33. Bailey JR, Bland PW, Tarlton JF, et al. IL-13 promotes collagen accumulation in Crohns disease fibrosis by down-regulation of fibroblast MMP synthesis: A role for innate lymphoid cells PLoS One. 2012;7:e52332.
34. McKaig BC, McWilliams D, Watson SA, et al. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease. Am J Pathol. 2003;162:1355-1360.
35. Baugh MD, Perry MJ, Hollander AP, et al. Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology. 1999;117:814-822.
36. Kirkegaard T, Hansen A, Bruun E, et al. Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohns disease. Gut. 2004;53:701-709.
37. Ammarguellat FZ, Gannon PO, Amiri F, et al. Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors. Hypertension. 2002;39:679-684.
38. Swiderski RE, Dencoff JE, Floerchinger CS, et al. Differential expression of extracellular matrix remodeling genes in a murine model of bleomycininduced pulmonary fibrosis. Am J Pathol. 1998;152:821-828.
39. Naito Y, Yoshikawa T. Role of matrix metalloproteinases in inflammatory bowel disease. Mol Aspects Med. 2005;26:379-390.
40. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463-516.
41. Gan X, Wong B, Wright SD, et al. Production of matrix metalloproteinase-9 in CaCO-2 cells in response to inflammatory stimuli. J Interferon Cytokine Res. 2001;21:93-98.
42. Nee LE, McMorrow T, Campbell E, et al. TNF-alpha and IL-1beta-mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells. Kidney Int. 2004;66:1376-1386.
43. Bataille F, Rohrmeier C, Bates R, et al. Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohns disease. Inflamm Bowel Dis. 2008;14:1514-1527.
44. Motomura Y, Khan WI, El-Sharkawy RT, et al. Induction of a fibrogenic response in mouse colon by overexpression of monocyte chemoattractant protein-1. Gut. 2006;55:662-670.
45. Sempowski GD, Chess PR, Phipps RP. CD40 is a functional activation antigen and B7-independent T cell costimulatory molecule on normal human lung fibroblasts. J Immunol. 1997;158:4670-4677.
46. Kaufman J, Sime PJ, Phipps RP. Expression of CD154 (CD40 ligand) by human lung fibroblasts: differential regulation by IFN-gamma and IL-13, and implications for fibrosis. J Immunol. 2004;172:1862-1871.